Cannabotech Ltd. Logo

Cannabotech Ltd.

CNTC | TA

Overview

Corporate Details

ISIN(s):
IL0011769085
LEI:
Country:
Israel
Address:
3 Arik Einstein, 4659071 Herzliya
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Cannabotech Ltd. is a biomedical company focused on the research, development, and commercialization of botanical medical solutions. The company's core strategy involves integrating the therapeutic properties of cannabinoids and functional mushrooms to create innovative healthcare products. Its pipeline includes preventative care solutions and treatments targeting various indications such as cancer, chronic pain, and inflammation. Cannabotech also develops personalized cannabinoid-based formulas, CBD-infused food supplements, and skincare products.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Cannabotech Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-02-10 17:47
Regulatory News Service
Base price of 1 agora and unlimited price fluctuation
Hebrew (modern) 90.8 KB
2025-01-09 10:41
Regulatory News Service
Capital consolidation 10:1, There will be no trading in the company's shares on…
Hebrew (modern) 77.6 KB
2024-11-12 18:33
Regulatory News Service
Trading in the company's shares (ISIN IL0011769085) will be renewed on Thursday…
Hebrew (modern) 158.8 KB
2024-10-01 10:13
Regulatory News Service
Suspension due to failure in publication of financial reports
Hebrew (modern) 79.6 KB
2024-09-29 17:58
Regulatory News Service
CANNABOTECH– Appointment of a Market Maker
Hebrew (modern) 151.8 KB
2024-09-23 19:44
Regulatory News Service
Failure in publishing financial reports-Notification
Hebrew (modern) 127.4 KB
2024-09-02 15:06
Regulatory News Service
Discontinuation of Market Making
Hebrew (modern) 92.1 KB
2022-01-11 15:43
Regulatory News Service
Opening of Trading on January 12 2022- CANNABOTECH W3
Hebrew (modern) 253.5 KB
2022-01-10 10:54
Regulatory News Service
Identifying Details of New Security-CANNABOTECH W3
Hebrew (modern) 174.6 KB
2021-09-13 19:45
Regulatory News Service
will not be added TA-Tech Elite Index
Hebrew (modern) 82.9 KB
2021-07-25 18:17
Regulatory News Service
Fast Track to TA-Tech Elite Index as on October 7th, 2021 at the end of the tra…
Hebrew (modern) 162.5 KB
2021-07-25 16:07
Regulatory News Service
Appointment of a Market Maker
Hebrew (modern) 210.0 KB
2021-07-21 18:34
Regulatory News Service
Identifying Details of New Securities - CANNABOTECH, CANNABOTECH W1, CANNABOTEC…
Hebrew (modern) 244.6 KB
2021-06-15 16:11
Regulatory News Service
Identifying Details of New Securities - CANNABOTECH, CANNABOTECH W1, CANNABOTEC…
Hebrew (modern) 155.0 KB

Automate Your Workflow. Get a real-time feed of all Cannabotech Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Cannabotech Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Captor Therapeutics S.A. Logo
Develops TPD drugs for oncology and autoimmune disorders, targeting 'undruggable' proteins.
Poland CTX
Developing engineered cellular medicines for regenerative treatment of heart failure.
United Kingdom N/A
Cellectis Logo
Biopharma using gene-editing to create off-the-shelf CAR T-cell cancer therapies.
France ALCLS
Celyad Oncology SA Logo
Clinical-stage biotech developing allogeneic & autologous CAR T-cell therapies for cancer.
Belgium CYAD
Cereno Scientific AB Logo
Clinical-stage biotech developing treatments for rare cardiovascular & pulmonary diseases.
Sweden CRNO
Ceres Power Holdings PLC Logo
Licensing solid oxide tech (SOFC/SOEC) for clean power and green hydrogen to global partners.
United Kingdom CWR
Cessatech A/S Logo
Develops non-invasive pain relief, like a nasal spray, for children.
Denmark CESSA
CHOSA Oncology AB Logo
Develops diagnostics and drug delivery for personalized cancer therapy.
Sweden CHOSA
Cinclus Pharma Holding AB Logo
Late-stage pharma developing a next-gen P-CAB drug for severe GERD and H. pylori.
Sweden CINPHA
Circio Holding ASA Logo
Developing circular RNA medicines for gene and cell therapies for hard-to-treat diseases.
Norway CRNA